Efficacy and safety of transcranial direct current stimulation in acute ischemic stroke

Efficacy and safety of transcranial direct current stimulation in acute ischemic stroke - Efficacy and safety of transcranial direct current stimulation in acute ischemic stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033929

Enrollment

Registered

2018-10-01

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

twenty-daily sessions of tDCS (n = 10) in 4 weeks. twenty-daily sessions of sham stimulation (n =10) in 4 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria were: (1) Age 18-80 (2) Clinical first ever ischemic cerebrovascular stroke confirmed by MRI (3) Acute phase of stroke (after 1 week after the stroke onset).

Exclusion criteria

Exclusion criteria: (1) Pre-stroke disability (2) Coexistent neurological or psychiatric disease (including epilepsy) as to decrease number of confounders (3) History of significant alcohol or drug abuse (4) Use of neuropsychotropic drugs, such as antidepressants or benzodiazepines.

Design outcomes

Primary

Measure	Time frame
Fugl-Meyer Assessment(FMA)	—

Countries

Japan

Contacts

Public ContactTakashi Shibata

University of Toyama Department of Neurosurgery

sibata@dj8.so-net.ne.jp0764347348

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026